Safety and effectiveness in pediatric patients 14 years of age and younger has not been established.
Indomethacin should not be prescribed for pediatric patients 14 years of age and younger unless toxicity or lack of efficacy associated with other drugs warrants the risk.
In experience with more than 900 pediatric patients reported in the literature or to the manufacturer who were treated with indomethacin capsules, side effects in pediatric patients were comparable to those reported in adults. Experience in pediatric patients has been confined to the use of indomethacin capsules.
If a decision is made to use indomethacin for pediatric patients two years of age or older, such patients should be monitored closely and periodic assessment of liver function is recommended. There have been cases of hepatotoxicity reported in pediatric patients with juvenile rheumatoid arthritis, including fatalities. If indomethacin treatment is instituted, a suggested starting dose is 1 mg/kg/day given in divided doses. Maximum daily dosage should not exceed 4 mg/kg/day or 150-200 mg/day, whichever is less. As symptoms subside, the total daily dosage should be reduced to the lowest level required to control symptoms, or the drug should be discontinued.
RebelMouse has a unique and ever-growing advantage through the mix of technology we've built, the amount of sites we power, and the relationships we have with our clients. We built off the founding team's knowledge — from their experience of building HuffPost — to create something truly exciting. Two of the most exciting new media breakout hits — The Dodo and Axios — were built by RebelMouse when they were just ideas. The Dodo now has their claim to fame with one of the most popular videos on Facebook ever , and every month brings in billions of Facebook views. Axios, launched only in January of this year, has become a traffic monster — racking up 80M+ page views a month. Now we've taken on Odyssey Online , and have grown it by 4M new users in the first 45 days alone.